a clinical trial to study the effects of per rectal misoprostol 400 microgram plus 5 units oxytocin iv and 5 units oxytocin iv in third stage of labour.
Not Applicable
Completed
- Registration Number
- CTRI/2010/091/006136
- Lead Sponsor
- Bankura Sammilani Medical College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
Women who will have spontaneous normal delivery of a live, singleton neonate, and absence of any contraindications for misoprostol or oxytocin use.
Exclusion Criteria
women delivered by cesarean, or had a history of antepartum hemorrhage or bleeding tendency. The diagnosis of hypertensive disorder with pregnancy or the need for anticoagulants also will serve as exclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method